Key result
Aortic valve preservation and repair demonstrated a low pooled early mortality of 2.6% and a late mortality of 1.3% per patient-year in selected patients with aortic valve pathology.
Why the study?
Does aortic valve preservation and repair provide safe and durable outcomes in adult patients with aortic valve pathology?
Systematic Review (n=2,891)
Does aortic valve preservation and repair provide safe and durable outcomes in adult patients with aortic valve pathology?
Aortic valve preservation and repair is a feasible alternative to replacement with low operative mortality (2.6%) and acceptable mid-term durability (92% freedom from re-intervention at 5 years).
Supports aortic valve preservation as alternative to replacement in selected patients; extends meta-analytic evidence on safety and durability.
BACKGROUND: Aortic valve repair has emerged as a feasible alternative to replacement in the surgical treatment of selected patients with aortic valve (AV) pathology. In order to provide a synopsis of the current literature, we preformed a systematic review with a focus on valve-related events following AV repair. METHODS: Structured keyword searches of Embase and PubMed were performed in January 2012. A study was eligible for inclusion if it reported early mortality, late mortality, or valve-related morbidity in the adult population. RESULTS: Initial search results identified 3,507 unique studies. After applying inclusion and exclusion criteria, 111 studies remained for full-text review. Of these, 17 studies involving 2,891 patients were included for quantitative assessment. No randomized trials were identified. Tricuspid and bicuspid AV pathologies were present in 65% (range, 21-100%) and 13.5% (range, 5-100%) of the population, respectively. Cusp repair techniques were applied in a median of 46% (range, 5-100%) of patients. The median requirement for early reoperation for post-operative bleeding and early reintervention for primary AV repair failure was 3% (range, 0-10%) and 2% (range, 0-16%), respectively. Pooled early mortality was 2.6% (95% CI: 1.4-4.4%, I(2) =0%). Late mortality and valve-related events were linearized [(number of events/number of patient-years) ×100] (%/pt-yr) for each study. Late operated valve endocarditis was reported at median event rate of 0.23%/pt-yr (range, 0-0.78%/pt-yr), while a composite outcome of neurological events and thromboembolism occurred at a median rate of 0.52%/pt-yr (0-0.95%/pt-yr). Late AV re-intervention requiring AV replacement or re-repair occurred at a rate of 2.4%/pt-yr (range, 0-4.2%/pt-yr). The median 5-year freedom from AV re-intervention and late recurrent aortic insufficiency >2+ estimated from survival curves was 92% (range, 87-98%) and 88% (range, 87-100%), respectively. Pooled late mortality produced summary estimate of 1.3%/pt-yr (95% CI: 0.9-2.1%, I(2) =0%). CONCLUSIONS: The present systematic review confirmed the low operative risk of patients who underwent aortic valve preservation and repair. There is a need for long-term follow-up studies with meticulous reporting of outcomes following AV repair, as well as comparative studies with aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Saczkowski et al. (2013) conducted a systematic review in Aortic valve pathology (n=2,891). Aortic valve preservation and repair was evaluated on Early mortality (95% CI 1.4-4.4). Aortic valve preservation and repair demonstrated a low pooled early mortality of 2.6% and a late mortality of 1.3% per patient-year in selected patients with aortic valve pathology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: